NCT02184195 2023-09-13
POLO
AstraZeneca
Phase 3 Completed
Clinical Trials
5 trialsNCT02511223 2023-04-19
10
Sheba Medical Center
Phase 2 Completed
NCT03205176 2021-05-06
AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas
AstraZeneca
Phase 1 Completed
NCT01296763 2016-03-22
Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00515866 2013-12-20
Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer
AstraZeneca
Phase 1 Completed